Corcept Therapeutics Incorporated (CORT)
NASDAQ: CORT · IEX Real-Time Price · USD
33.24
-0.10 (-0.30%)
Jul 17, 2024, 4:00 PM EDT - Market closed

Corcept Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Ending
CurrentDec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019 2018 - 2002
Market Capitalization
3,4613,3482,1862,2863,0391,383
Upgrade
Market Cap Growth
11.57%53.13%-4.36%-24.78%119.78%-10.37%
Upgrade
Enterprise Value
3,0502,9801,7562,0632,6011,110
Upgrade
PE Ratio
31.3631.7421.5920.3228.6714.68
Upgrade
PS Ratio
6.616.945.446.258.594.51
Upgrade
PB Ratio
6.326.614.366.085.813.73
Upgrade
P/FCF Ratio
27.7526.3818.2313.6520.1610.24
Upgrade
P/OCF Ratio
27.7226.3518.1713.6220.0010.16
Upgrade
EV/Sales Ratio
5.836.184.375.647.353.62
Upgrade
EV/EBITDA Ratio
24.8227.3415.1416.1219.949.76
Upgrade
EV/EBIT Ratio
25.1927.9515.6116.5720.299.95
Upgrade
EV/FCF Ratio
24.4623.4814.6412.3217.268.22
Upgrade
Debt / Equity Ratio
0.000.000.000.000.000.01
Upgrade
Debt / EBITDA Ratio
0.000.000.010.000.020.03
Upgrade
Debt / FCF Ratio
0.000.000.010.000.020.03
Upgrade
Quick Ratio
4.863.926.385.289.837.62
Upgrade
Current Ratio
5.184.396.895.6110.077.91
Upgrade
Asset Turnover
0.870.820.770.690.690.86
Upgrade
Return on Equity (ROE)
24.20%22.00%22.20%23.10%22.60%29.20%
Upgrade
Return on Assets (ROA)
19.60%17.90%19.50%21.10%20.70%26.40%
Upgrade
Return on Capital (ROIC)
18.59%18.02%19.54%29.77%19.64%24.05%
Upgrade
Earnings Yield
3.39%3.15%4.63%4.92%3.49%6.81%
Upgrade
FCF Yield
3.60%3.79%5.48%7.32%4.96%9.76%
Upgrade
Buyback Yield / Dilution
4.77%3.64%7.94%-1.42%-1.33%3.25%
Upgrade
Total Shareholder Return
4.77%3.64%7.94%-1.42%-1.33%3.25%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).